Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$215.3M
-24.2% from 2023
Prescriptions
179K
$1,203.66 per claim
Patients
38K
29,951 prescribers
Total spending, 2024
$215.4M
$5,658.44 per patient
Medicare prescription drug plans paid $215.3M for Bydureon Bcise in 2024, for 178,845 prescriptions and refills to 38,039 patients (down 24.2% from 2023). The average cost per claim was $1,203.66.
Texas had the highest Medicare cost for Bydureon Bcise in 2024: $26.9M for 18,424 claims, followed by New Jersey ($14.8M).
Manuel J Palafox, internal medicine in El Paso, TX, had the highest Medicare cost for Bydureon Bcise in 2024: 126 claims costing $247K.
Bydureon Bcise is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Manuel J Palafox El Paso, TX | Internal Medicine | 126 | 51 | $247K |
| Theofanis Mitsinikos Stony Brook, NY | Endocrinology | 106 | 31 | $217K |
| Carlos Garcia Fajardo |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 38,334 | 276,996 | 54,535 | $354.9M |
| 2023 | 34,075 | 212,648 | 45,828 | $283.9M |
| 2024 | 29,951 | 178,845 | 38,039 | $215.3M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Family Practice |
| 100 |
| 34 |
| $197K |
| Patricia Lane Pleasanton, TX | Family Practice | 117 | 29 | $190K |
| Manuel Martinez San Antonio, TX | Internal Medicine | 73 | 27 | $179K |
| Alberto Flores Fort Worth, TX | Internal Medicine | 147 | 41 | $163K |
| Gerald Miceli Ormond Beach, FL | Endocrinology | 216 | 40 | $160K |
| Angela S Jones-Allen El Paso, TX | Family Practice | 65 | 29 | $151K |
| Avegiyel E Dunn Portland, TX | Family Practice | 63 | 26 | $149K |
| Hernan R Baquerizo Miami, FL | Endocrinology | 113 | 24 | $149K |
| Gregory D McCarroll San Antonio, TX | Internal Medicine | 96 | 19 | $145K |
| Enrique J Griego McAllen, TX | Family Practice | 105 | 24 | $138K |
| John A Fritz Jersey City, NJ | Family Practice | 161 | 20 | $136K |
| Luis F Bieler San Antonio, TX | Internal Medicine | 66 | 19 | $134K |
| Dominic F Homan Gadsden, AL | Endocrinology | 81 | 19 | $134K |
| Kandarp B Patel Jackson, TN | Cardiology | 143 | 34 | $131K |
| Marcel B Twahirwa Edinburg, TX | Endocrinology | 83 | 22 | $124K |
| Karla A Perez Corpus Christi, TX | Family Practice | 70 | 21 | $124K |
| Prachi J Italiya Corpus Christi, TX | Family Practice | 55 | 21 | $123K |
| Rohit Dwivedi Surprise, AZ | Endocrinology | 83 | 18 | $120K |
| Anita P Raghuwanshi Cape May Court House, NJ | Endocrinology | 78 | 26 | $119K |
| Shashi Mittal San Antonio, TX | Family Practice | 50 | 16 | $116K |
| Eleanora E Saenz San Antonio, TX | Internal Medicine | 73 | 21 | $115K |
| Kristopher R Koch San Antonio, TX | Internal Medicine | 45 | 18 | $113K |
| Silvia M Cuadra Mongalo Port Orange, FL | Endocrinology | 162 | 41 | $113K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Astrazeneca AZN | 178,931 | $215.4M |